RU92006245A - METHOD OF DIAGNOSTICS OF MALIGNANT INTESTINAL FORMATIONS - Google Patents

METHOD OF DIAGNOSTICS OF MALIGNANT INTESTINAL FORMATIONS

Info

Publication number
RU92006245A
RU92006245A RU92006245/14A RU92006245A RU92006245A RU 92006245 A RU92006245 A RU 92006245A RU 92006245/14 A RU92006245/14 A RU 92006245/14A RU 92006245 A RU92006245 A RU 92006245A RU 92006245 A RU92006245 A RU 92006245A
Authority
RU
Russia
Prior art keywords
diagnostics
formations
malignant
diagnosed
malignant intestinal
Prior art date
Application number
RU92006245/14A
Other languages
Russian (ru)
Other versions
RU2056053C1 (en
Inventor
А.А. Машевский
В.И. Прохорова
Т.П. Цырусь
Л.А. Путырский
Original Assignee
Научно-исследовательский институт онкологии и медицинской радиологии
Filing date
Publication date
Application filed by Научно-исследовательский институт онкологии и медицинской радиологии filed Critical Научно-исследовательский институт онкологии и медицинской радиологии
Priority to RU92006245A priority Critical patent/RU2056053C1/en
Priority claimed from RU92006245A external-priority patent/RU2056053C1/en
Publication of RU92006245A publication Critical patent/RU92006245A/en
Application granted granted Critical
Publication of RU2056053C1 publication Critical patent/RU2056053C1/en

Links

Claims (1)

Использование: в медицине, клинической онкологии, лабораторных методах исследования. Технический результат: повышение точности и чувствительности способа. Сущность : при температуре 37°С измеряется (с помощью серийного ЭПР спектрометра ПС-100х) способность сыворотки крови связывать вводимый в образец парамагнитный зонд. Злокачественное образование диагностируют по величине коэффициента связывания. При значении коэффициента связывания больше 2 диагностируют злокачественное новообразование кишечника.Use: in medicine, clinical oncology, laboratory research methods. EFFECT: increased accuracy and sensitivity of the method. Essence: at 37 ° C, the ability of serum to bind a paramagnetic probe introduced into a sample is measured (using a PS-100x serial EPR spectrometer). Malignant tumors are diagnosed by the magnitude of the binding coefficient. If the binding coefficient is greater than 2, a malignant neoplasm of the intestine is diagnosed.
RU92006245A 1992-11-18 1992-11-18 Method for diagnosis of intestine malignant tumors RU2056053C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU92006245A RU2056053C1 (en) 1992-11-18 1992-11-18 Method for diagnosis of intestine malignant tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU92006245A RU2056053C1 (en) 1992-11-18 1992-11-18 Method for diagnosis of intestine malignant tumors

Publications (2)

Publication Number Publication Date
RU92006245A true RU92006245A (en) 1995-09-10
RU2056053C1 RU2056053C1 (en) 1996-03-10

Family

ID=20132057

Family Applications (1)

Application Number Title Priority Date Filing Date
RU92006245A RU2056053C1 (en) 1992-11-18 1992-11-18 Method for diagnosis of intestine malignant tumors

Country Status (1)

Country Link
RU (1) RU2056053C1 (en)

Similar Documents

Publication Publication Date Title
IT1130254B (en) PROCEDURE FOR DETECTING LIGANDS IN TEST SAMPLES AND RELATED ANALYTICAL REAGENT
TR200101200T2 (en) Design by ligand imaging and X-ray crystallography.
DK462675A (en) DIAGNOSTIC TEST STRIP FOR DETECTION AND FOR SALM QUANTITATIVE DETERMINATION OF OCCULT BLOOD AND OF HEMOGLOBIN IN BIOLOGICAL MATERIALS
Virgilio et al. Measuring intragastric tumor markers in gastric cancer patients: a systematic literature review on significance and reliability
BR8606860A (en) IMMUNOSENSE PROCESS TO DETECT ASSOCIATED ANTIGEN OF A HUMAN CARCINOMA IN A PATHOLOGICAL SAMPLE, IMMUNOENSATION TEST SET, IMMUNOSENSE TEST AND PROCESS TO IDENTIFY MARKERS OF SOSIDED TUMORS IN NEOASTIC TISSUE
Shani et al. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma
Schechter Measurement of Fast Biochemical Reactions: Flow and relaxation methods are being used to study chemical processes in biological macromolecules.
IL52095A0 (en) Analytical or clinical derivatives tagged derivatives and methods of analysis using such derivatives
RU92006245A (en) METHOD OF DIAGNOSTICS OF MALIGNANT INTESTINAL FORMATIONS
CN101685080B (en) Method for analyzing proteome in biological sample
Henderson Thin-layer chromatography of free porphyrins for diagnosis of porphyria.
Child et al. Biochemical markers in Hodgkin’s disease and non-Hodgkin’s lymphoma
NO179344C (en) Method for examining a blood sample and measuring polarized fluorescence radiation
RU92006244A (en) METHOD OF DIAGNOSTICS OF MALIGNANT LUNG FORMATIONS
Douwes et al. Immunodiagnostics of Malignant Disease VI. Electrophoretic Mobility Test (EMT) in Malignant Melanoma
RU2056052C1 (en) Method for diagnosis of lungs malignant tumors
EP1636587A4 (en) Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein
STADEN et al. Differential lectin reactivities of α‐fetoprotein in hepatocellular carcinoma: Diagnostic value when serum α‐fetoprotein levels are slightly raised
RU2093832C1 (en) Method of immunological diagnosis of malignant neoplasm
Orozco et al. Solid phase C1q microassay for the rapid detection of circulating immune complexes
RU2056059C1 (en) Method for diagnosis of malignant tumors
RU2056053C1 (en) Method for diagnosis of intestine malignant tumors
Yoshii et al. Screening for Colorectal Cancer in Clinical Practice Evaluation of Fecal Occult Blood Testing on Two Successive Days
Leblanc et al. Staphylococcal protein A assay for detection of antibody directed at renal cancer cells
SU1741078A1 (en) Method for detecting hbs antigen in blood